Article Information
History
- November 29, 2022.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC 4.0 International license.
Author Information
- aBiocruces-Bizkaia Health Research Institute, Barakaldo, Spain
- bBiomedical Research Doctorate Program, University of the Basque Country, Leioa, Spain
- cDepartment of Cell Biology and Histology, University of the Basque Country, Leioa, Spain
- dIKERBASQUE Basque Foundation for Science, Bilbao, Spain
- ↵*Corresponding author at: Computational Neuroimaging Laboratory, Biocruces-Bizkaia Health Research Institute, Plaza Cruces S/N, 48903 Barakaldo, Bizkaia, Spain Email address: jorge.garciacondado{at}osakidetza.eus (J. Garcia Condado), jesus.m.cortes{at}gmail.com (J.M. Cortes)
Posted November 29, 2022.
NeuropsychBrainAge: a biomarker for conversion from mild cognitive impairment to Alzheimer’s disease
